Certainly not GLP-1 drugs, who are now set to go mainstream. As the patent expires, the Indian markets will be flush with low-cost options. But, experts warn, indiscriminate jab-hopping may cost you more than you think

“Spring break time and I’m trying something new,” she captioned the post.  US ski champ Lindsey Vonn replied: “Love this! Need to get you some better gear, then you’ll be cruising!”